1. PAD Home
  2. Taking XARELTO®
  3. Staying on XARELTO®

Staying the Course with Your
XARELTO® Treatment

Sticking to a medication regimen isn’t always easy. We understand that you need to feel like you’re doing all you can for yourself and those who depend on you to help protect yourself from blood clots that can cause a heart attack or stroke. When the going gets tough, remember how important it is to learn all you can and continue taking XARELTO® as prescribed by your healthcare professional. Now that’s something you and your loved ones can be proud of.

Here are some tips and reminders that may help as you refocus on your health goals:

Register for Janssen CarePath Patient Support for XARELTO®

Learn more about ongoing support from Janssen CarePath. You’ll receive additional information about peripheral artery disease (PAD) and XARELTO®, and access to other tools and resources to help you get started and stay on track.

Learn about saving on XARELTO® costs

If you haven’t yet, explore your savings options for XARELTO®. If your health coverage has changed since you started taking XARELTO®, you may want to recheck your eligibility.

Download the Care4Today® Connect App

Make it easier to remember to take and refill your medication by setting reminders in the Care4Today® Connect App. You can also track your health activity and create reports to share with your healthcare professional.

Remember that XARELTO® helps keep you protected

Doing what you can to help keep yourself protected from the risk of a life-threatening heart attack or stroke is very important. In a clinical trial, almost 96% of people taking XARELTO® with their low-dose aspirin did not have a heart attack, stroke, or die from a cardiovascular event.* When you register with Janssen CarePath Patient Support for XARELTO®, you can sign up for medication reminders to help you stay the course with your treatment.

*The rate of the first event like a stroke, heart attack, or cardiovascular death was 4.1% for people taking XARELTO® plus aspirin vs 5.4% for aspirin alone. Patients were followed for an average of 23 months.